SABCS 2023 Breast Cancer Highlights - NATALEE, MONARCH-3, INAVO120, TROPION-Breast01

In discussion with Dr. Hope Rugo, covering the San Antonio Breast Cancer Symposium 2023 Highlights from Community Oncology perspective. We covered 4 important practice informing studies with Dr. Rugo:
- NATALEE Update - Ribociclib + Nonsteroidal AI as Adj Treatment in Patients with HR+/HER2− Early Breast Cancer: Final iDFS analysis
- MONARCH 3 - Final OS Results of Abemaciclib Plus a Nonsteroidal AI as First-line Therapy for HR+, HER2- Advanced Breast Cancer
- INAVO120 - Phase III Study of Inavolisib or Placebo in Combination with Palbociclib and Fulvestrant in Patients with PIK3CA-mut, HR+, HER2- Locally Adv/Metastatic Breast Cancer
- TROPION-Breast01 - Phase III Study of Dato-DXd vs Chemo for Patients with Previously Treated Inoperable/Metastatic HR+, HER2- Breast Cancer
#SABCS #Endocrine #Sensitive #Breast #Cancer #2023 #oncology #oncbrothers
Website: www.oncbrothers.com/
Twitter: / oncbrothers
Contact us at [e-mail]

[@sulfasalazina]

Thanks for this nice presentation

[@WATERBURG]

dr Rugo!!!!!!!